Nanjing Vazyme Biotech Co., Ltd.SSE: 688105

(688105)"NANJING VAZYME BIOTECH CO., LTD."Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026

· Issued by Nanjing Vazyme Biotech Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 688105 · · 3 pages · Chinese

Summary by 6ix AI

The meeting confirmed the approval of two significant proposals, including a change of the accounting firm and amendments to the company's registered capital and address.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

On 6ix: 6ix.com/news/688105nanjing-vazyme-biotech-co-ltdannouncement-on-resolutions-of-the-2nd-extraordinary-general-meeting-in-2026

Release

Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Nanjing Vazyme Biotech Co., Ltd. on 6ix

Story so far

Earlier from Nanjing Vazyme Biotech

Later from Nanjing Vazyme Biotech

All Nanjing Vazyme Biotech news releases